File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Lack of association between adiponectin levels and atherosclerosis in mice

TitleLack of association between adiponectin levels and atherosclerosis in mice
Authors
Issue Date2010
Citation
Arteriosclerosis, Thrombosis, and Vascular Biology, 2010, v. 30 n. 6, p. 1159-1165 How to Cite?
AbstractObjective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models. © 2010 American Heart Association, Inc.
Persistent Identifierhttp://hdl.handle.net/10722/194274
ISSN
2015 Impact Factor: 5.969
2015 SCImago Journal Rankings: 3.356
ISI Accession Number ID

 

DC FieldValueLanguage
dc.contributor.authorNawrocki, AR-
dc.contributor.authorHofmann, SM-
dc.contributor.authorTeupser, D-
dc.contributor.authorBasford, JE-
dc.contributor.authorDurand, JL-
dc.contributor.authorJelicks, LA-
dc.contributor.authorWoo, CW-
dc.contributor.authorKuriakose, G-
dc.contributor.authorFactor, SM-
dc.contributor.authorTanowitz, HB-
dc.contributor.authorHui, DY-
dc.contributor.authorTabas, I-
dc.contributor.authorScherer, PE-
dc.date.accessioned2014-01-30T03:32:23Z-
dc.date.available2014-01-30T03:32:23Z-
dc.date.issued2010-
dc.identifier.citationArteriosclerosis, Thrombosis, and Vascular Biology, 2010, v. 30 n. 6, p. 1159-1165-
dc.identifier.issn1079-5642-
dc.identifier.urihttp://hdl.handle.net/10722/194274-
dc.description.abstractObjective: Adiponectin is an adipocyte-derived, secreted protein that is implicated in protection against a cluster of related metabolic disorders. Mice lacking adiponectin display impaired hepatic insulin sensitivity and respond only partially to peroxisome proliferator-activated receptor γ agonists. Adiponectin has been associated with antiinflammatory and antiatherogenic properties; however, the direct involvement of adiponectin on the atherogenic process has not been studied. Methods and results: We crossed adiponectin knockout mice (Adn) or mice with chronically elevated adiponectin levels (Adn) into the low-density lipoprotein receptor-null (Ldlr) and the apoliprotein E-null (Apoe) mouse models. Adiponectin levels did not correlate with a suppression of the atherogenic process. Plaque volume in the aortic root, cholesterol accumulation in the aorta, and plaque morphology under various dietary conditions were not affected by circulating adiponectin levels. In light of the strong associations reported for adiponectin with cardiovascular disease in humans, the lack of a phenotype in gain-and loss-of-function studies in mice suggests a lack of causation for adiponectin in inhibiting the buildup of atherosclerotic lesions. Conclusion: These data indicate that the actions of adiponectin on the cardiovascular system are complex and multifaceted, with a minimal direct impact on atherosclerotic plaque formation in preclinical rodent models. © 2010 American Heart Association, Inc.-
dc.languageeng-
dc.relation.ispartofArteriosclerosis, Thrombosis, and Vascular Biology-
dc.titleLack of association between adiponectin levels and atherosclerosis in mice-
dc.typeArticle-
dc.description.naturelink_to_subscribed_fulltext-
dc.identifier.doi10.1161/ATVBAHA.109.195826-
dc.identifier.pmid20299691-
dc.identifier.scopuseid_2-s2.0-77952887207-
dc.identifier.volume30-
dc.identifier.issue6-
dc.identifier.spage1159-
dc.identifier.epage1165-
dc.identifier.isiWOS:000277860900014-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats